These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17178965)

  • 1. Preoperative positron emission tomography to evaluate potentially resectable hepatic colorectal metastases.
    Joyce DL; Wahl RL; Patel PV; Schulick RD; Gearhart SL; Choti MA
    Arch Surg; 2006 Dec; 141(12):1220-6; discussion 1227. PubMed ID: 17178965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraoperative sonography in patients with colorectal cancer and resectable liver metastases on preoperative FDG-PET-CT.
    Wildi SM; Gubler C; Hany T; Petrowsky H; Clavien PA; Jochum W; Gerlach T; Fried M; Mullhaupt B
    J Clin Ultrasound; 2008 Jan; 36(1):20-6. PubMed ID: 17937421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of PET before liver resection on surgical management for colorectal adenocarcinoma metastases: a randomized clinical trial.
    Moulton CA; Gu CS; Law CH; Tandan VR; Hart R; Quan D; Fairfull Smith RJ; Jalink DW; Husien M; Serrano PE; Hendler AL; Haider MA; Ruo L; Gulenchyn KY; Finch T; Julian JA; Levine MN; Gallinger S
    JAMA; 2014 May; 311(18):1863-9. PubMed ID: 24825641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of intraoperative sonography for revealing hepatic metastases from colorectal cancer in patients selected for surgery after undergoing FDG PET.
    Rydzewski B; Dehdashti F; Gordon BA; Teefey SA; Strasberg SM; Siegel BA
    AJR Am J Roentgenol; 2002 Feb; 178(2):353-8. PubMed ID: 11804891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases.
    Wiering B; Krabbe PF; Jager GJ; Oyen WJ; Ruers TJ
    Cancer; 2005 Dec; 104(12):2658-70. PubMed ID: 16315241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective evaluation of the impact of [18F]fluoro-2-deoxy-D-glucose positron emission tomography of resectable colorectal liver metastases.
    Truant S; Huglo D; Hebbar M; Ernst O; Steinling M; Pruvot FR
    Br J Surg; 2005 Mar; 92(3):362-9. PubMed ID: 15672427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-analysis exploring the role of PET and PET-CT in the management of potentially resectable colorectal cancer liver metastases.
    Daza JF; Solis NM; Parpia S; Gallinger S; Moulton CA; Belley-Cote EP; Levine MN; Serrano PE
    Eur J Surg Oncol; 2019 Aug; 45(8):1341-1348. PubMed ID: 30928334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does
    Jonsson J; Hemmingsson O; Strengbom R; Axelsson J; Riklund K; Nyström H
    Scand J Surg; 2022; 111(1):14574969221083144. PubMed ID: 35348393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resection of liver metastases from colorectal cancer: does preoperative chemotherapy affect the accuracy of PET in preoperative planning?
    Adie S; Yip C; Chu F; Morris DL
    ANZ J Surg; 2009 May; 79(5):358-61. PubMed ID: 19566517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in nontherapeutic laparotomy rates in patients undergoing surgical therapy for hepatic colorectal metastases.
    Pawlik TM; Assumpcao L; Vossen JA; Buijs M; Gleisner AL; Schulick RD; Choti MA
    Ann Surg Oncol; 2009 Feb; 16(2):371-8. PubMed ID: 19020939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of multiphase CT, FDG-PET and intra-operative ultrasound in patients with colorectal liver metastases selected for surgery.
    Wiering B; Ruers TJ; Krabbe PF; Dekker HM; Oyen WJ
    Ann Surg Oncol; 2007 Feb; 14(2):818-26. PubMed ID: 17136470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of positron emission tomography for predicting chemotherapy response in colorectal cancer liver metastases.
    Glazer ES; Beaty K; Abdalla EK; Vauthey JN; Curley SA
    Arch Surg; 2010 Apr; 145(4):340-5; discussion 345. PubMed ID: 20404283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of FDG-PET in the selection of patients with colorectal liver metastases.
    Wiering B; Krabbe PF; Dekker HM; Oyen WJ; Ruers TJ
    Ann Surg Oncol; 2007 Feb; 14(2):771-9. PubMed ID: 17086488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Added value of positron emission tomography imaging in the surgical treatment of colorectal liver metastases.
    Wiering B; Adang EM; van der Sijp JR; Roumen RM; de Jong KP; Comans EF; Pruim J; Dekker HM; Ruers TJ; Krabbe PF; Oyen WJ
    Nucl Med Commun; 2010 Nov; 31(11):938-44. PubMed ID: 20856152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of PET-CT in pre-surgical staging of colorectal cancer hepatic metastases].
    Ramos E; Martínez L; Gámez C; Torras J; Valls C; Rafecas A; Lladó L; Jorba R; Ruiz S; Serrano T; Fabregat J
    Cir Esp; 2008 Aug; 84(2):71-7. PubMed ID: 18682184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of F-18 FDG positron emission tomography in preoperative assessment of the liver in patients being considered for curative resection of hepatic metastases from colorectal cancer.
    Rohren EM; Paulson EK; Hagge R; Wong TZ; Killius J; Clavien PA; Nelson RC
    Clin Nucl Med; 2002 Aug; 27(8):550-5. PubMed ID: 12169999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron Emission Tomography Combined With Computed Tomography vs. No Positron Emission Tomography Combined With Computed Tomography for the Management of Patients With Resectable Colorectal Cancer Liver Metastases and Synchronous Extrahepatic Disease.
    Serrano PE; Gu CS; Moulton CA; Gallinger S
    Am Surg; 2021 Sep; 87(9):1431-1437. PubMed ID: 33345573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of ¹⁸F-FDG-PET in decision making for liver metastectomy of colorectal cancer.
    McLeish AR; Lee ST; Byrne AJ; Scott AM
    ANZ J Surg; 2012; 82(1-2):30-5. PubMed ID: 22507492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolving role of staging laparoscopy in the treatment of colorectal hepatic metastasis.
    Thaler K; Kanneganti S; Khajanchee Y; Wilson C; Swanstrom L; Hansen PD
    Arch Surg; 2005 Aug; 140(8):727-34. PubMed ID: 16103281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of FDG-positron emission tomography for the evaluation of colorectal metastases of the liver.
    Boykin KN; Zibari GB; Lilien DL; McMillan RW; Aultman DF; McDonald JC
    Am Surg; 1999 Dec; 65(12):1183-5. PubMed ID: 10597072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.